nach oben

Reactions Weekly

Erschienen in:

01.06.2019 | Case report

Ferric carboxymaltose

Anaphylactic reaction: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Cococcioni L, et al. Safety and efficacy of ferric carboxymaltose [FCM] for the treatment of iron deficiency anaemia in paediatric patients affected by inflammatory bowel disease (pIBD). Journal of Pediatric Gastroenterology and Nutrition 68 (Suppl. 1): 509, May 2019. Available from: URL: http://doi.org/10.1097/MPG.0000000000002403 [abstract] - United Kingdom

Titel: Ferric carboxymaltose
Anaphylactic reaction: case report
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-64006-4

Springer Medizin

Ferric carboxymaltose

Anaphylactic reaction: case report

Excerpt

Weitere Artikel der Ausgabe 1/2019

Thiamazole

Anakinra

No evidence of harm with long-term pantoprazole?

Mirtazapine

Theophylline

Posaconazole

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Thiamazole

Anakinra

No evidence of harm with long-term pantoprazole?

Mirtazapine

Theophylline

Posaconazole